Stay updated on MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Sign up to get notified when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.
Latest updates to the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded a unified Locations section listing all study sites by state, and removed the prior state-specific Locations headings. This centralizes site information and clarifies where the study is taking place.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 has been added, replacing the previous v3.2.0.SummaryDifference0.0%
- Check38 days agoChange DetectedA notice about government funding and potential updates on NIH operations was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check52 days agoChange DetectedStudy NCT04795713 (MT-6402) is terminated by the sponsor; enrollment reached 64 and completion date is 2024-10-31.SummaryDifference0.3%
- Check81 days agoChange DetectedMajor update adds a funding/status notice and marks revision to v3.2.0; a specific resource title was removed (v3.1.0).SummaryDifference2%
- Check88 days agoChange DetectedUpdated medical naming to a more specific form and bumped the revision version from v3.0.2 to v3.1.0.SummaryDifference0.4%
Stay in the know with updates to MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.